CRNN and lip and oral cavity carcinoma: Follow-up studies to monitor Cornulin levels throughout the clinical course of disease and relative survival rate data are needed to firmly establish this promising biomarker in the clinical setting to supplement current pathological assessment and prognosis for patients afflicted with oral cancer.